Onconic Therapeutics Inc. (KOSDAQ:476060)
19,450
-600 (-2.99%)
Jan 19, 2026, 3:30 PM KST
413.53% (1Y)
| Market Cap | 865.33B |
| Revenue (ttm) | 46.65B |
| Net Income (ttm) | 16.75B |
| Shares Out | 44.49M |
| EPS (ttm) | 1,513.84 |
| PE Ratio | 12.85 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 645,053 |
| Average Volume | 2,723,744 |
| Open | 20,000 |
| Previous Close | 20,050 |
| Day's Range | 19,000 - 20,100 |
| 52-Week Range | 3,138 - 26,600 |
| Beta | n/a |
| RSI | 49.37 |
| Earnings Date | Mar 13, 2026 |